Syringin exhibits anticancer effects in HeLa human cervical cancer cells by inducing apoptosis, cell cycle arrest and inhibition of cell migration

Authors

  • Ning Xia Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110-022 Department of Obsterics and Gynecology, Central Hospital affliated to Shenyang Medical College, Shenyang, 110-024 http://orcid.org/0000-0003-1350-9271

DOI:

https://doi.org/10.3329/bjp.v11i4.27755

Keywords:

Apoptosis, Cancer, Cell cycle, Cell migration, HeLa human cervical cancer cell, Syringin

Abstract

The present study was aimed at to demonstrate the antitumor effects of syringin in HeLa human cervical cancer cells. Its effects on apoptosis, cell cycle phase distribution as well as on cell migration were also examined. The effect on cell proliferation was evaluated by MTT assay, while as effects on colony formation were assessed using clonogenic assay. Syringin inhibited cancer cell growth in HeLa cells in a time-dependent as well as in a concentration-dependent manner. Syringin also led to inhibition of colony formation efficacy with complete suppression at 100 µM drug dose. Syringin could induce G2/M cell cycle arrest along with slight sub-G1 cell cycle arrest. HeLa cells began to emit red fluorescence as the dose of syringin increased from 0 µM in vehicle control to 100 µM. Syringin also inhibited cell migration in a dose-dependent manner with 100 µM dose of syringin leading to 100% inhibition of cell migration.

Video Clip of Methodology:

Clonogenic assay: 4 min 21 sec   Full Screen   Alternative

 

 

Downloads

Download data is not yet available.
Abstract
1596
Download
689 Read
722

Downloads

Additional Files

Published

2016-10-01

How to Cite

Xia, N. “Syringin Exhibits Anticancer Effects in HeLa Human Cervical Cancer Cells by Inducing Apoptosis, Cell Cycle Arrest and Inhibition of Cell Migration”. Bangladesh Journal of Pharmacology, vol. 11, no. 4, Oct. 2016, pp. 838-43, doi:10.3329/bjp.v11i4.27755.

Issue

Vol. 11 No. 4 (2016)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).